Evolution of Lung Disease Studied by Computed Tomography in Adults with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor

Evolution of Lung Disease Studied by Computed Tomography in Adults with Cystic Fibrosis Treated with Elexacaftor/Tezacaftor/Ivacaftor

Elexacaftor–tezacaftor–ivacaftor (ETI) has shown clinical and spirometric benefits in cystic fibrosis (CF). CT remains a vital tool for diagnosing and monitoring structural lung disease. This study aimed to assess the evolution of lung disease, as evaluated through CT, in adults with CF after at lea...

Full description

Saved in:
Bibliographic Details
Main Authors: Susana Hernández-Muñiz, Paloma Caballero, Adrián Peláez, Marta Solís-García, Carmen de Benavides, Javier Collada, Ignacio Díaz-Lorenzo, Cristina Zorzo, Rosa Mar Gómez-Punter, Rosa María Girón
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Journal of Imaging
Subjects:
cystic fibrosis
CFTR (cystic fibrosis transmembrane conductance regulator) modulator therapy
elexacaftor/tezacaftor/ivacaftor
chest imaging
computed tomography
Online Access:https://www.mdpi.com/2313-433X/11/4/124
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2313-433X/11/4/124

Similar Items